Cerence, Inc.

How big is Cerence, Inc.?

As of Jun 18, Cerence, Inc. has a market capitalization of 359.04 million and reported net sales of 254.25 million with a net profit of -336.59 million over the latest four quarters. As of Sep 24, shareholder's funds are 141.10 million, and total assets are 702.36 million.

As of Jun 18, Cerence, Inc. has a market capitalization of 359.04 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 254.25 million, while the sum of net profit for the same period is -336.59 million.<BR><BR>As of Sep 24, the shareholder's funds are reported at 141.10 million, and total assets amount to 702.36 million.

What does Cerence, Inc. do?

Cerence, Inc. develops automotive cognitive assistance solutions and operates in the micro-cap market with a recent net sales of $78 million and a net profit of $22 million. The company has a market cap of $359.04 million and key metrics include a P/E ratio of 9.00 and a return on equity of 31.77%.

Overview: <BR>Cerence, Inc. is focused on developing automotive cognitive assistance solutions within the Software Products industry and operates in the micro-cap market.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 78 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 22 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 359.04 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 9.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.93 <BR>Return on Equity: 31.77% <BR>Price to Book: 2.41<BR><BR>Contact Details: <BR>Address: 15 Wayside Rd, BURLINGTON MA: 01880 <BR>Tel: ['1 617 5800843', '1 617 9874799'] <BR>Fax: 1 302 6555049 <BR>Website: http://www.cerence.com/

Should I buy, sell or hold Cerence, Inc.?

Who are in the management team of Cerence, Inc.?

As of March 2022, the management team of Cerence, Inc. includes Arun Sarin (Independent Non-Executive Chairman), Sanjay Dhawan (CEO and Director), Thomas Beaudoin (Director), and Independent Directors Marianne Budnik, Sanjay Jha, and Kristi Matus. They oversee the company's strategic direction and operations.

As of March 2022, the management team of Cerence, Inc. includes the following individuals:<BR><BR>- Mr. Arun Sarin, who serves as the Independent Non-Executive Chairman of the Board.<BR>- Mr. Sanjay Dhawan, the Chief Executive Officer and a Director.<BR>- Mr. Thomas Beaudoin, who is a Director.<BR>- Ms. Marianne Budnik, an Independent Director.<BR>- Mr. Sanjay Jha, also an Independent Director.<BR>- Ms. Kristi Matus, another Independent Director. <BR><BR>This team is responsible for guiding the company's strategic direction and overseeing its operations.

Is Cerence, Inc. overvalued or undervalued?

As of August 9, 2022, Cerence, Inc. appears overvalued with a high EV/EBITDA ratio of 28.81 and a P/E ratio of 409.37 compared to peers, despite strong ROE and past performance, indicating a cautious outlook.

As of 9 August 2022, Cerence, Inc. moved from fair to risky, indicating a shift towards a more cautious outlook. The company appears overvalued based on its current valuation metrics. The P/E ratio stands at 9, while the EV to EBITDA ratio is a high 28.81, and the PEG ratio is exceptionally low at 0.03, suggesting that the stock may not be justified at its current price given its earnings growth prospects.<BR><BR>In comparison to its peers, Cerence's P/E ratio of 409.37 is significantly higher than Definitive Healthcare Corp.'s 8.68, which indicates a stark valuation disparity. Additionally, the company's ROE of 31.77% is impressive, yet it is overshadowed by the high valuation ratios that raise concerns about sustainability. Over the past year, Cerence has outperformed the S&P 500 with a return of 364.54% compared to the index's 17.14%, but this strong performance may not be enough to justify its current valuation.

Is Cerence, Inc. technically bullish or bearish?

As of October 10, 2025, Cerence, Inc. shows a mildly bullish trend supported by various indicators, having outperformed the S&P 500 recently, but underperformed over the longer term.

As of 10 October 2025, the technical trend for Cerence, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. Bollinger Bands and Dow Theory also indicate a mildly bullish stance on both weekly and monthly time frames. The daily moving averages are mildly bullish, and the KST is bullish on both weekly and monthly periods. However, the RSI shows no signal for both time frames, and the OBV indicates no trend on the weekly chart but is mildly bullish monthly.<BR><BR>In terms of performance, Cerence has outperformed the S&P 500 over the past month with an 8.96% return compared to the S&P 500's 0.31%, and significantly over the past year with a return of 235.61% versus 13.36%. However, it has underperformed over the longer-term periods of 3 and 5 years. Overall, the current technical stance is mildly bullish, supported by several indicators, despite some mixed signals.